Global scenario of microbes, infections, antibiotics and resistance - By Dr. A.J. Tamhankar

-APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market Aztreonam for Injection, USP in two dosage strengths. Aztreonam is therapeutically equivalent to the reference-listed drug Azactam®, which is marketed by Bristol-Myers Squibb.

-Sampling of pigeons captured on the streets of Madrid has revealed that Chlamydophila psittaci and Campylobacter jejuni were highly prevalent in the bird population, , both of which cause illness in humans-e.g.Diorrhea.

-Scientists have completed the most comprehensive comparative analysis to date of bacterial communities inhabiting the human nose and throat, which could provide new insights into why some individuals become colonized with pathogens while others do not. They released their findings in mBio™ the online open-access journal published by the American Society for Microbiology.

-shift in the balance between the "good" bacteria and the "bad" bacteria that populate our gut could be a harbinger of colon cancer.

-Discovery Of the mechanisms by which pathogenic bacterial populations control the way they spread over the surface of the organs they infect and stop when they detect the presence of an antibiotic, Could Help To Design New Strategies To Increase Their Sensitivity To Antibiotics.

-Hospira Receives FDA Approval For Meropenem For Injection, USP (I.V.)

-New, high-powered genomic analytical techniques have established that as many as 1,000 different single-celled species coexist in relative harmony in every healthy human gut.

-United States (U.S.) CDC has issued new and important guidelines on the detection of Mycobacterium tuberculosis infections, the causative agent of tuberculosis (TB). In these landmark guidelines, CDC advises that Interferon Gamma Release Assay (IGRA) blood tests are now preferred over the 100+-year-old tuberculin skin test (TST) for diagnosing TB infection in certain populations

-Survival Rate Up To 100% For Late Stage Treatment Of Anthrax Infections

-A new study indicates different delivery methods of newborn babies has a big effect on the types of microbial communities they harbor

-In a bid to reduce levels of the sexually transmitted infection (STI) chlamydia among young people in London, sexual health charity Terrence Higgins Trust will be inviting young people attending this year's Pride London to take a free chlamydia test during their day out.
-FDA seeks less use of antibiotics in animals to keep them effective for humans (The Washington post)
-News from Europe-A cross-border project including MRSA surveillance and prophylaxis is launched in the European Region of Maas-Rhein, a region including parts of Germany, Belgium and the Netherlands; Norway –New routines for how to report a patient with previously diagnosed MRSA, when he/she is again found positive suggested. Denmark- Decision for stopping the use of cephalosporins in pig farming and doctors demand tougher rules for veterinary AB use; the head of doctors’ union points out that in Denmark 130 tons of ABs are used annually for animals, while only 48 tons for humans. ; Comparison of the sales of veterinary antibacterial agents between 10 European countries